Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ankitgupta.iitg
    Junior Member
    • Oct 2009
    • 1

    #1

    Problems with de novo transcriptome assembly using 454 Titanium series

    Hi,

    I am trying to do a de novo transcriptome assembly for a non-model organism using 454 GS FLX Titanium series. I have 656878 reads with average length of 377 base pairs which after cleaning, masking and assembling using TGICL (uses CAP3 to assemble), I have 87282 contigs and 317205 singletons. My contigs have an average length of 700 bp and an average coverage depth of 1.9.

    I am afraid that the coverage is very low and am not getting enough contigs due to the large number of singletons. Any ideas on how can I improve my assembly? Are these problems inherent to the TGICL assembly program or should I use some other software like MIRA? Are there any other parameters that I should look at to give me a better idea about the quality of my contigs and assembly?

    Thanks
  • 454Sequencing
    Member
    • Apr 2009
    • 22

    #2
    Hi ankitgupta.iitg,

    If you've not heard previously, 454 Life Sciences will shortly launch a new transcriptome assembler as part of our next product update. I think you will find this new tool extremely useful in your de novo transcriptome assembly efforts. For more details please see the following:



    In the meantime, I'd recommend following up with your Roche representative. One of our bioinformatics Regional Applications Consultants should be able to lend a hand with your question.

    Best regards,
    Jason

    Technical Product Manager
    454 Life Sciences, A Roche Company
    Technical Product Manager
    454 Life Sciences, A Roche Company

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Working...